Affiliation:
1. Vascular Surgery Clinic, Dedinje Cardiovascular Institute University of Belgrade – Faculty of Medicine
2. Vascular Surgery Clinic, Dedinje Cardiovascular Institute
Abstract
Treatment of patients taking anticoagulant therapy (ACT) and antiplatelet therapy (APT) is a daily challenge for doctors of all specialities, and a special problem is the adequate care of these patients in the immediate perioperative period during vascular surgical procedures. This paper presents the current findings and recommendations on the perioperative use of ACT and APT and considerations of therapeutic modalities in frequent clinical cases of vascular patients. An overview of the most commonly used anticoagulant and antiplatelet drugs in clinical practice is also presented. Vascular surgical patients represent a population of patients in whom platelet coagulation and aggregation mechanism are dysregulated in many cases. There is still no broad consensus and unequivocal evidence that can direct the physician towards the right modality of therapy. The final decision rests with the physician, who should, based on the individual assessment of each patient, determine the risk and thus determine the modality of anticoagulant and antiplatelet therapy.
Publisher
Hellenic Society of Vascular and Endovascular Surgery
Reference33 articles.
1. Gutierrez JJP, Rocuts KR. Perioperative Anticoagulation Management. StatPearls. Treasure Island: StatPearls Publishing; 2022.
2. Wagner J, Lock JF, Kastner C, Klein I, Krajinovic K, Löb S, et al. Perioperative management of anticoagulant therapy. Innov Surg Sci. 2019;4:144-51.
3. Briete LD, Towers WF, Bone R, Nair R, Steck M, Cutshall BT, et al. Perioperative Anticoagulation Management. Crit Care Nurs Q. 2022;45:119-31.
4. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Sta- tistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56-528.
5. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-21.